Scientific Committee
TempoZero’s Scientific Committee brings together international experts who have been studying Lafora disease for years, alongside leading professionals in translational research, clinical development and innovative therapies.
SCIENTIFIC COMMITTEE
Dr. Roberto Michelucci
Neurologist, specialist in epilepsy and clinical neurophysiology
Former Director of Neurology, IRCCS Institute of Neurological Sciences of Bologna
Expert in the clinical study of Lafora disease
Berge A. Minassian, M.D.
Professor of Pediatrics, Neurology and Neuroscience, UT Southwestern Medical Center
Division Chief of Child Neurology
Matthew S. Gentry, Ph.D.
Professor and Chair, Department of Biochemistry and Molecular Biology, University of Florida
Director, Lafora Epilepsy Cure Initiative
Souad Messahel, Ph.D.
Expert in rare disease and gene therapy program development
Chief Operating Officer, AurelixBio
Maurizio Scaltriti, Ph.D.
Vice President, Translational Medicine, Early Oncology, Oncology R&D, AstraZeneca


